Related Experiment Video
Updated: Jun 17, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
Published on: November 29, 2024
Delivery of therapeutic proteins
Dipak S Pisal1, Matthew P Kosloski, Sathy V Balu-Iyer
1Department of Pharmaceutical Sciences, 521 Hochstetter Hall, University at Buffalo, The State University of New York, Amherst, New York 14260, USA.
Protein therapeutic limitations like instability and short half-lives can be overcome with novel drug modifications and advanced delivery systems. These strategies aim to enhance the next generation of protein therapeutics.
Area of Science:
- Biopharmaceutical Sciences
- Drug Delivery Systems
- Protein Engineering
Background:
- Protein therapeutics face challenges including instability, immunogenicity, and short circulation half-lives, limiting their clinical application.
- Existing protein drugs often require frequent administration and can elicit immune responses, impacting patient compliance and treatment effectiveness.
Purpose of the Study:
- To review novel strategies for improving protein therapeutic delivery and overcoming key pharmaceutical limitations.
- To discuss advancements in drug modification and formulation for next-generation protein therapeutics.
Main Methods:
- Review of current literature on protein therapeutic modifications.
- Analysis of drug delivery approaches including poly(ethylene glycol) (PEG)ylation, polysialylation, and nanoparticulate systems.
- Discussion of formulation strategies such as liposomes, polymeric microspheres, and nanoparticles.
Main Results:
- Covalent attachment of polymers like PEG, polysialic acid, or glycolic acid can enhance protein stability and half-life.
- Nanoparticulate and colloidal systems offer alternative formulation approaches for improved protein delivery.
- These modifications and formulations show promise for developing advanced protein therapeutics.
Conclusions:
- Novel drug modifications and advanced delivery systems are crucial for overcoming the inherent limitations of protein therapeutics.
- Strategies like PEGylation and nanoparticle encapsulation represent key advancements for next-generation protein drugs.
- Further research into these delivery approaches will facilitate the development of more effective and safer protein-based medicines.
Related Concept Videos
Production of Pharmaceuticals
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
Modified-Release Drug Delivery Systems: Site-Targeted
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...

